Achieve Life Sciences, Inc.

ACHV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-5.5M
Depreciation & Amortization —
Depreciation $50.0K
Amortization —
Stock-Based Compensation $380.0K
Net Cash from Operating Activities $34.9M
Investing Activities
Capital Expenditures $15.0K
Business Acquisitions —
Net Cash from Investing Activities $2.2M
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $17.3M
Net Change in Cash $54.4M
Free Cash Flow $34.9M
← Newer Page 3 of 3 Older →